Literature DB >> 2299587

Acute effects of nicotine on prolactin release in the rat: agonist and antagonist effects of a single injection of nicotine.

B A Hulihan-Giblin1, M D Lumpkin, K J Kellar.   

Abstract

The effects of nicotine on prolactin release were studied in conscious, unrestrained rats in which an indwelling jugular cannula allowed multiple samplings of blood after i.v. administration of nicotine. Intravenous administration of nicotine bitartrate dihydrate increases plasma prolactin concentrations in a dose-dependent manner with an ED50 of approximately 100 micrograms/kg (200 nmol/kg) and this effect is blocked completely by pretreatment with mecamylamine, indicating that it is mediated by a nicotinic cholinergic receptor. Intracerebral ventricular injection of 1 microgram of nicotine also increases plasma prolactin levels, but i.v. injection of this same amount of nicotine has no effect, indicating that nicotine acts within the brain to release prolactin. A single i.v. injection of nicotine resulted in desensitization of the prolactin response to a subsequent injection of nicotine given 1 to 2 hr later, thus confirming a previous report by Sharp and Beyer (J. Pharmacol. Exp. Ther. 238: 486-491, 1986). The prolactin response to nicotine was restored within 24 hr after a single injection. The acute desensitization after a single injection of nicotine appears to be specific to release of prolactin by nicotine because the prolactin response to morphine was unaffected 1 hr after injection of nicotine. A single injection of nicotine appears to desensitize the prolactin response to a subsequent injection of nicotine with an ED50 of approximately 20 micrograms/kg (40 nmol/kg), indicating that nicotine is even more potent in stimulating desensitization of nicotinic cholinergic receptors than in stimulating prolactin release. These results support the concept that nicotine acts as a time-averaged antagonist.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2299587

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  22 in total

1.  Sazetidine-A, a selective α4β2 nicotinic acetylcholine receptor ligand: effects on dizocilpine and scopolamine-induced attentional impairments in female Sprague-Dawley rats.

Authors:  Amir H Rezvani; Marty Cauley; Hannah Sexton; Yingxian Xiao; Milton L Brown; Mikell A Paige; Brian E McDowell; Kenneth J Kellar; Edward D Levin
Journal:  Psychopharmacology (Berl)       Date:  2011-01-28       Impact factor: 4.530

2.  Nicotinic receptor-mediated reduction in L-DOPA-induced dyskinesias may occur via desensitization.

Authors:  Tanuja Bordia; Carla Campos; J Michael McIntosh; Maryka Quik
Journal:  J Pharmacol Exp Ther       Date:  2010-03-03       Impact factor: 4.030

3.  Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior.

Authors:  Jill R Turner; Laura M Castellano; Julie A Blendy
Journal:  J Pharmacol Exp Ther       Date:  2010-04-30       Impact factor: 4.030

4.  86Rb+ efflux mediated by alpha4beta2*-nicotinic acetylcholine receptors with high and low-sensitivity to stimulation by acetylcholine display similar agonist-induced desensitization.

Authors:  Michael J Marks; Natalie M Meinerz; Robert W B Brown; Allan C Collins
Journal:  Biochem Pharmacol       Date:  2010-06-30       Impact factor: 5.858

5.  Anxiolytic-like and anxiogenic-like effects of nicotine are regulated via diverse action at β2*nicotinic acetylcholine receptors.

Authors:  S M Anderson; D H Brunzell
Journal:  Br J Pharmacol       Date:  2015-03-24       Impact factor: 8.739

6.  Evidence of cellular nicotinic receptor desensitization in rats exhibiting nicotine-induced acute tolerance.

Authors:  Susan E Robinson; John R James; Laura N Lapp; Robert E Vann; Daniel F Gross; Scott D Philibin; John A Rosecrans
Journal:  Psychopharmacology (Berl)       Date:  2005-07-12       Impact factor: 4.530

7.  Effectiveness of nicotinic agonists as desensitizers at presynaptic α4β2- and α4α5β2-nicotinic acetylcholine receptors.

Authors:  Charles R Wageman; Michael J Marks; Sharon R Grady
Journal:  Nicotine Tob Res       Date:  2013-09-19       Impact factor: 4.244

8.  Chemistry and pharmacological studies of 3-alkoxy-2,5-disubstituted-pyridinyl compounds as novel selective α4β2 nicotinic acetylcholine receptor ligands that reduce alcohol intake in rats.

Authors:  Yong Liu; Janell Richardson; Thao Tran; Nour Al-Muhtasib; Teresa Xie; Venkata Mahidhar Yenugonda; Hannah G Sexton; Amir H Rezvani; Edward D Levin; Niaz Sahibzada; Kenneth J Kellar; Milton L Brown; Yingxian Xiao; Mikell Paige
Journal:  J Med Chem       Date:  2013-04-01       Impact factor: 7.446

9.  Menthol Enhances the Desensitization of Human α3β4 Nicotinic Acetylcholine Receptors.

Authors:  Hoai T Ton; Amanda E Smart; Brittany L Aguilar; Thao T Olson; Kenneth J Kellar; Gerard P Ahern
Journal:  Mol Pharmacol       Date:  2015-05-11       Impact factor: 4.436

10.  Chronic sazetidine-A maintains anxiolytic effects and slower weight gain following chronic nicotine without maintaining increased density of nicotinic receptors in rodent brain.

Authors:  G Patrick Hussmann; Kristen E DeDominicis; Jill R Turner; Robert P Yasuda; Jacquelyn Klehm; Patrick A Forcelli; Yingxian Xiao; Janell R Richardson; Niaz Sahibzada; Barry B Wolfe; Jon Lindstrom; Julie A Blendy; Kenneth J Kellar
Journal:  J Neurochem       Date:  2014-02-07       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.